The Coca-Cola Company (KO) — Coverage File
The Coca-Cola Company (KO) — Coverage File
Data as of: Q2 2026 (quarter ended July 3, 2026); FY2025 10-K filed Feb 20, 2026; latest source Barclays conference, Sep 9, 2026 File last updated: October 10, 2026 (initial build)
0. 30-second reopen
- Business: An asset-light concentrate business with 32 billion-dollar brands, selling through a mostly independent bottling system that moves 33.8B unit cases (2.2B servings a day) in 200+ countries; 34.9% GAAP operating margin in H1 2026 and ~$12B of annual free cash flow.
- Core debate: With inflation pricing gone, can volume (~2%) and real pricing (~2–3%) keep organic growth in the 4–6% algorithm, and does the Eleventh Circuit hand back the IRS deposit or impose a ~$21B tax bill?
- Base thesis: A royalty-like franchise whose margins keep rising as the last bottlers are sold, funding a 63-year dividend streak without stretching the balance sheet.
- Main bear case: Growth settles at the industry's 3–4% while the stock prices more; an IRS loss, sugar taxes or more write-downs on non-core deals cut the per-share value further.
- What to watch: Two-year unit case growth vs. price/mix, Asia Pacific price/mix, operating margin ex-currency, the Eleventh Circuit ruling, Mexico volume, FCF vs. dividends.
- Valuation: ~$379B market cap, ~29x 2025 comparable EPS, ~27x the 2026 guide, ~3.2% FCF yield on guidance (Oct 9, 2026 web price) — priced for steady high-single-digit EPS growth.
1. Business snapshot
Coca-Cola owns the brands and sells concentrate and syrup to bottlers, which make, distribute and sell the finished drinks. The system sold 33.8B unit cases in 2025; sparkling soft drinks were 69% of volume and Trademark Coca-Cola alone 47%; 84% of volume was outside the U.S., with Mexico, China, Brazil and India together 33% [FY2025 10-K]. FY2025 revenue was $47.9B (+2% reported, +5% organic) [FY2025 10-K; 2026 proxy].
Concentrate operations produced 59% of 2025 revenue against 40% in 2016; the rest is finished product, mainly the company-owned bottlers in the Bottling Investments segment, which earn far more revenue per case at far lower margins [FY2025 10-K; FY2016 10-K]. Bottlers must buy their concentrate from Coca-Cola, which can generally change its price unilaterally, but bottlers' ability to pass increases on limits it [FY2025 10-K]. The five largest bottlers (Coca-Cola FEMSA, CCEP, CCHBC, Arca Continental, Swire) handle 44% of volume, and one bottler accounted for 10% of 2025 revenue [FY2025 10-K]. Coca-Cola also holds $20.8B of equity-method stakes, including bottlers such as CCEP and CCHBC, which contributed $2.0B of equity income in 2025 [Q2 2026 10-Q; FY2025 10-K].
Geographic segments earn 31–64% operating margins (Q2 2026: Latin America 64.0%, Asia Pacific 44.1%, EMEA 42.4%, North America 31.4%), against 6.1% for Bottling Investments [Q2 2026 10-Q].
2. Core debate
The first question is what growth looks like after inflation. Price/mix ran 10–11% a year in 2022–24, but most of it was inflationary pricing that currency took back (2024: EMEA price/mix +17%, currency −16%) [FY2024 10-K]. Price/mix fell to 4% in 2025 and 2% in Q2 2026, with Asia Pacific −9 points as the company invested in affordability [FY2025 10-K; Q2 2026 10-Q]. Volume answered in 2026 (unit cases +5% in Q2, ~2% on a two-year basis), helped by the World Cup, weather and an easy comparison [Q2 FY2026 call]. Whether volume and real pricing together hold organic growth inside the 4–6% algorithm decides the EPS path.
The second is the IRS case. The Eleventh Circuit heard Coca-Cola's appeal of the Tax Court transfer-pricing decision on June 25, 2026; a ruling is expected 6–12 months later [Q2 2026 10-Q; Q2 FY2026 call]. A win returns a 14B for 2010–25 and raises the tax rate ~3.8 points a year [Q2 2026 10-Q].
3. Base thesis
Coca-Cola collects something close to a royalty on the world's drinking habits. Bottlers carry the plants, trucks and labour; Coca-Cola carries brands, marketing and concentrate, so each extra case and each real price increase falls through at high margin on about $2.2B of annual capex [Q2 2026 10-Q]. Selling its own bottlers has moved revenue toward concentrate and lifted operating margin from 20.6% (2016) to 28.7% (2025, after a $960M impairment) and 34.9% in H1 2026 [FY2016 10-K; FY2025 10-K; Q2 2026 10-Q]. Most of the profit becomes cash and goes out as a dividend that has risen for 63 years [Q4 FY2025 call].
Assumptions this rests on:
- Volume grows ~2% a year and pricing adds 2–3% without inflation's help, keeping organic revenue in the 4–6% long-term algorithm [Q2 FY2026 call].
- Comparable operating margin keeps expanding as concentrate's share rises; the sale of Coca-Cola Beverages Africa (CCBA) to CCHBC, expected to close late 2026, is the next step [Q2 2026 10-Q].
- Free cash flow of ~$12B a year covers the dividend at ~75% payout while net debt stays below the 2–2.5x EBITDA target [Q4 FY2025 call].
- The IRS dispute ends without a permanent tax step-up; management judges a win "more likely than not" and reserves only $529M [Q2 2026 10-Q].
4. Main bear case
The bear case is not a collapse; it is a stalwart whose multiple assumes more than the industry can give. Strip out inflation and Coca-Cola's volume has grown ~1.6% a year since 2016 (29.3B to 33.8B unit cases; computed) [FY2016 10-K; FY2025 10-K]. 2025 showed what a year without inflation pricing looks like: flat unit cases, North America −1%, Mexico −4%, comparable EPS +4% after five points of currency headwind [FY2025 10-K; Q4 FY2025 call]. Asia Pacific is now buying volume with price, and the core is exposed to sugar taxes: Mexico raised its tax "significantly" in January 2026 [Q4 FY2025 call].
How it breaks: the Eleventh Circuit rules for the IRS, taking ~$21B of cash and receivables and ~5% of EPS permanently (computed); two-year volume slips below 2% with price/mix at 2% or less, putting organic growth under the algorithm's floor; and money keeps leaking into acquisitions that are later written down while buybacks only offset dilution. At ~27–29x earnings, any of these resets the price more than the business.
5. Business quality
High and durable. The moat is the combination of brands and a system no rival can replicate: 32 billion-dollar brands [CAGNY 2026], 33 million outlets served [Barclays conf. Sep 2026] and exclusive bottler territories under bottler's agreements [FY2025 10-K]. Capital intensity is low: capex was $2.1B on $47.9B of revenue in 2025 (4.4%), and about 25% of 2026 capex goes to company-owned bottlers [FY2025 10-K; Q4 FY2025 call]. Suppliers are paid on 120-day terms, and a receivables factoring program (sold $7.0B in H1 2026) shortens the cash cycle further [Q2 2026 10-Q].
The weak points: pricing power runs through independent bottlers whose finances and retailer negotiations limit it; the brand core is sugared sparkling drinks in a world taxing sugar; and a large share of earnings is booked in emerging-market currencies (currency cut 2025 operating income 12%) [FY2025 10-K].
6. Key value drivers
Revenue = concentrate volume × price/mix × currency ± structural changes. Volume: unit cases at the consumer level, and concentrate shipments, which can run ahead or behind (Q4 2025 shipments led unit cases by 3 points; 2026 shipments should trail slightly) [Q4 FY2025 call; Q2 2026 10-Q]. Price/mix: pricing actions (3 points in Q2 2026) less category, package and geographic mix (−1 point) [Q2 FY2026 call]. Margin: concentrate share, marketing (advertising $1,565M in Q2 2026 vs. $1,328M) and commodity costs [Q2 2026 10-Q]. Below the line: equity income from bottlers, the tax rate (19.9% underlying 2026 guide) and interest income on the IRS deposit, booked in the tax line [Q2 2026 10-Q]. Per share: the share count, which has not fallen in nine years (§9).
7. Financial profile
History. Revenue fell from $41.9B (2016) to $34.3B (2018) as bottlers were sold, then rose to $47.9B (2025); operating margin rose from 20.6% to 28.7% [FY2016, FY2019, FY2025 10-Ks]. Comparable EPS was "stuck" near $2 for years before reaching $3.00 in 2025 [Q4 FY2025 call].
FY2025. Revenue $47,941M; operating income $13,762M (28.7%), after a $960M BodyArmor impairment; net income $13,107M; diluted EPS $3.04 (comparable $3.00, +4%) [FY2025 10-K; Q4 FY2025 call]. Operating cash flow was $7,408M after the $6.1B final fairlife milestone payment; free cash flow excluding that payment was $11.4B; dividends $8,779M; buybacks $634M under the plan [FY2025 10-K; 2026 proxy]. A $1,274M impairment was booked on the CCBA stake held for sale [Q2 2026 10-Q].
H1 2026. Revenue $25,852M (+9%; Q2 organic +6%), operating income $9,031M (+14%; 34.9% margin, currency +4 points), net income $8,349M; Q2 comparable EPS $0.97, +11% with 2 points from currency [Q2 2026 10-Q; Q2 FY2026 call]. Operating cash flow $7,543M, capex 6.9B), helped by factoring, lower tax payments and currency [Q2 2026 10-Q]. At July 3, 2026: total debt $43.5B, cash and investments 27.2B, computed), equity $36.2B; net debt/EBITDA 1.4x [Q2 2026 10-Q; Q2 FY2026 call].
2026 guidance. Organic revenue ~5%; comparable EPS +9–10% vs. 12.2B ($14.4B operating cash flow less $2.2B capex) [Q2 FY2026 call; Q4 FY2025 call].
8. Valuation
Management's algorithm is 4–6% organic revenue growth with modest margin expansion, implying high-single-digit EPS growth; the CFO frames the industry at 3–4% and Coca-Cola's ambition as the high end of 4–6% [Q2 FY2026 call]. At ~27x the 2026 guide and a 3.2% FCF yield, the price assumes that algorithm holds for many years with no IRS loss. The IRS exposure ($21B including the deposit) equals ~5.6% of the market cap (computed). Note the Bull & Bear memo used $75.53, the average KO paid for its own shares in H1 2026 [Q2 2026 10-Q]; at the current price its multiples are about 17% higher.
Market data (outside sources/, web, dated) Share price 378.8B; dividend $2.12 (2.4% yield) (stockanalysis.com, retrieved Oct 10, 2026). Derived by this file from filings: 4,302.5M shares at Jul 27, 2026; TTM revenue $50.1B, TTM GAAP operating income $14.9B, TTM net income $14.3B; FY2025 comparable EPS 3.27–3.30; net debt ~406B, ~27x TTM operating income, FCF yield ~3.2% on the $12.2B guide (~3.8% on TTM reported FCF, flattered by timing and factoring).
9. Management & capital allocation
Henrique Braun, a 30-year company veteran and former COO, became CEO on March 31, 2026; James Quincey, his predecessor, is Executive Chairman [8-K Dec 10, 2025]. John Murphy is President and CFO and has also run North America on an interim basis since its president left on July 31, 2026 [8-K Jun 25, 2026]. A Chief Digital Officer role was created under the CEO [8-K Jan 14, 2026]. Braun's priorities are consumer-centricity, "constructive discontent" and digital at the core, not a change of strategy [CAGNY 2026; Barclays conf. Sep 2026].
Capital priorities, in order: reinvest, grow the dividend, "consumer-centric" acquisitions, then buybacks of excess cash; 2026 buybacks are set to offset dilution only [Q2 2026 10-Q]. Shares outstanding were 4,302.5M in July 2026 against 4,293.5M in February 2017 [Q2 2026 10-Q; FY2016 10-K]. The record is mixed: refranchising worked; fairlife was a success that cost a 5.6B for the remaining 85% in 2021) has been impaired by 741M, 2025), India territories ($218M, 2025) and CCBA (pending) [Q2 2026 10-Q].
Pay: Quincey's 2025 total compensation was $31.2M (1,739x the median employee). PSUs weight revenue growth, EPS growth and cumulative FCF equally, with a ±25% relative-TSR modifier vs. the S&P 500 Consumer Staples; the 2023–25 PSUs paid 229% [2026 proxy]. Annual-incentive targets have been set at the midpoint of the public algorithm [2026 proxy]. Insider transaction data is not in sources.
Claims to verify over time:
- GLP-1 drugs have a limited effect on total beverage spending [AGM 2026].
- Asia Pacific affordability spending is an investment that later returns as pricing, as it did in Latin America [Q2 FY2026 call].
- The World Cup lift reflects durable capability, not a one-off [Q2 FY2026 call].
10. Risks ranked by damage
1. Growth settles at the industry rate while the multiple prices more Damage rank: High · Permanence: High · Fixability: Low Mechanism: Without inflation pricing, organic growth falls toward 3–4%, EPS growth to mid-single digits, and a ~27–29x multiple contracts. Evidence today: price/mix 11% (2024) → 4% (2025) → 2% (Q2 2026); 2025 unit cases flat; 2026 volume strength partly from events and an easy comparison [FY2024 10-K; FY2025 10-K; Q2 FY2026 call]. What would confirm it: two-year unit case growth below 2% with price/mix at or below 2%. Impact: permanent loss on the price paid, even with the franchise intact.
2. IRS appeal lost Damage rank: High · Permanence: High · Fixability: Low Mechanism: The Tax Court's transfer-pricing method is upheld and applied to later years. Evidence today: $6.0B deposit plus 14B for 2010–25 plus ~$0.9B accrued in H1 2026, ~3.8-point higher tax rate; reserve 15B of new cash out, about 1.2 years of guided FCF, likely borrowed.
3. Sugar taxes, health regulation and weight-loss drugs Damage rank: Medium · Permanence: Medium · Fixability: Medium Mechanism: Taxes and rules shrink sugared sparkling volume, the highest-margin part of the system. Evidence today: Mexico's January 2026 tax increase, Mexico volume −4% (2025) and −1% (H1 2026); U.S. SNAP restrictions called "manageable"; the 10-K lists weight-loss drugs and a possible federal excise tax [FY2025 10-K; Q2 2026 10-Q; Q4 FY2025 call]. What would confirm it: more large markets copy Mexico; Trademark Coca-Cola volume falls outside event quarters. Impact: step-downs in volume and mix that pricing only partly recovers.
4. Capital allocation outside the core Damage rank: Medium · Permanence: Medium · Fixability: High Mechanism: Acquisitions rank ahead of buybacks and have a record of write-downs, while repurchases only offset dilution. Evidence today: BodyArmor impairments of $1.72B; flat share count since 2017; new CEO and an interim head of North America (§9). What would confirm it: a large non-core deal or another impairment. Impact: per-share value grows slower than earnings power.
5. Currency and emerging-market concentration Damage rank: Medium · Permanence: Low · Fixability: Low Mechanism: Most profit is earned outside the U.S., much of it in volatile currencies. Evidence today: currency cut 2025 operating income 12% and added 4–5 points in H1 2026 [FY2025 10-K; Q2 2026 10-Q]. What would confirm it: a renewed dollar rally. Impact: reported EPS swings, not franchise value.
6. Operational and cyber incidents Damage rank: Low · Permanence: Low · Fixability: High Mechanism: Disruption at owned production. Evidence today: a July 2026 ransomware event at fairlife suspended production temporarily; management expects no material impact [Q2 2026 10-Q]. What would confirm it: lost shelf space or a repeat. Impact: small and temporary.
11. Metrics to monitor
| Metric | Why it matters | Prior | Latest | As of |
|---|---|---|---|---|
| Unit case volume growth | §3 assumption 1; §10 risk 1 | 0% (FY2025) | +5% (two-year ~2%) | Q2 2026 |
| Price/mix (total / Asia Pacific) | Real pricing vs. bought volume | +4% (FY2025) | +2% / −9 pts | Q2 2026 |
| Organic revenue growth | 4–6% algorithm | 5% (FY2025) | 6%; FY2026 guide ~5% | Q2 2026 |
| GAAP operating margin | §3 assumption 2 | 28.7% (FY2025) | 34.9% | Q2 2026 |
| Comparable EPS growth (currency effect) | Earnings quality | +4% (−5 pts FX, FY2025) | +11% (+2 pts FX) | Q2 2026 |
| Free cash flow vs. dividends | §3 assumption 3 | $11.4B ex-fairlife / $8.8B (FY2025) | ~$6.9B / $4.6B (H1) | H1 2026 |
| Net debt / EBITDA | Balance-sheet room for an IRS loss | 1.6x (FY2025) | 1.4x | Q2 2026 |
| IRS exposure and reserve | §10 risk 2 | ~$14B; deposit $6.0B (Dec 2025) | +~$0.9B in H1; reserve $529M | Q2 2026 |
| Mexico unit case volume | §10 risk 3 | −4% (FY2025) | −1% (H1), even (Q2) | Q2 2026 |
| Shares outstanding | Buyback effectiveness | 4,293.5M (Feb 2017) | 4,302.5M | Jul 27, 2026 |
12. Thesis tripwires
| Direction | Tripwire |
|---|---|
| Stronger | Eleventh Circuit rules for Coca-Cola; the $6.5B deposit and interest come back and buybacks rise above dilution |
| Stronger | Two-year unit case growth holds above 2% with price/mix positive in Asia Pacific |
| Stronger | Operating margin rises after CCBA closes without currency help |
| Weaker | Organic growth below 4% for a full year |
| Weaker | Another BodyArmor impairment or a large non-core acquisition |
| Weaker | A second top-four volume market raises sugar taxes sharply |
| Breaks | The Eleventh Circuit upholds the Tax Court method for later years |
| Breaks | Dividend growth funded by rising leverage above the 2–2.5x target |
13. Open questions
- How large is Mexico's 2026 tax increase, and how much volume has it cost after pricing? Not in sources.
- What are the CCBA sale proceeds and the margin uplift once it is deconsolidated?
- How much of H1 2026 operating cash flow came from factoring and timing rather than earnings?
- What does capital allocation look like after the IRS ruling, either way?
- What is the comparable operating margin level? Calls give only changes, and the earnings-release exhibits are not in sources/.
14. Update log
| Date | Trigger | What changed | Impact on thesis |
|---|---|---|---|
| 2026-10-10 | Initial build | Initial Coverage File created from the FY2016–FY2025 10-Ks, the Q2 2026 10-Q, the 2026 proxy, 8-Ks from Dec 2025 to Jun 2026, and the Q4 FY2025 and Q2 FY2026 calls, CAGNY, AGM and Barclays 2026 transcripts. Oriented by the same-day Bull & Bear memo, whose multiples used the $75.53 H1 2026 buyback price; at the $88.05 web close (§8 only, labelled) they are about 17% higher. Earnings-release exhibits (99.1) are not in sources/, so comparable figures come from calls. | Baseline established. |
15. Source map
| Document | Period / date | Used for |
|---|---|---|
| Form 10-K | FY2025 (filed 2026-02-20) | Business model, volume mix, bottlers, segment results, financials, cash flow, BodyArmor, IRS exposure, risk factors |
| Forms 10-K | FY2016, FY2019, FY2021–FY2024 | Revenue, margin, price/mix and currency history; concentrate share; BodyArmor price; 2017 share count |
| Form 10-Q | Q2 2026 (quarter ended 2026-07-03; filed 2026-07-29, labelled FY2026_Q3 in sources) | H1 results, segment margins, IRS case, CCBA sale, fairlife incident, liquidity, buybacks, share count |
| Proxy statement (DEF 14A) | 2026-03-16 | 2025 results summary, CEO pay, PSU design and payout |
| Current reports (8-K) | 2025-12-10, 2026-01-14, 2026-02-20, 2026-06-25 | CEO succession, digital role, pay letters, North America leadership |
| Earnings call transcripts | Q4 FY2025 (2026-02-10), Q2 FY2026 (2026-07-28) | Comparable results, guidance, FCF, leverage, IRS timing, Mexico, SNAP |
| Conference transcripts | CAGNY (2026-02-17), AGM (2026-04-29), Barclays (2026-09-09) | Strategy, billion-dollar brands, GLP-1 view, outlets, affordability |
| Web market data (stockanalysis.com) | 2026-10-09 close | §8 market-data callout only |
| Coca-Cola — Bull & Bear Memo; Business Overview; KO-vs-PEP Peer Duel | 2026 | Orientation only (prior work, not evidence) |
